Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 |
|---|---|---|
| Total income (before exceptional items) | 158† | — |
| Net profit | 20 | 4 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Chetan Bipinchandra Shah | Executive Director | June 30, 2026 |
| Deval Rajnikant Shah | Executive Director | June 30, 2026 |
| Swapnil Jatinbhai Shah | Executive Director | June 30, 2026 |
| Kalpit Rajesh Gandhi | Independent Director | June 30, 2026 |
| Manjuladevi Pratul Shroff | Independent Director | June 30, 2026 |
| Naresh Bansilal Shah | Independent Director | June 30, 2026 |
| Udayan Dileep Choksi | Independent Director | June 30, 2026 |
| Ashokbhai Vijaysinh Barot | Non-Executive Director | June 30, 2026 |
| Hemanshu Nitinchandra Pandya | Non-Executive Director | June 30, 2026 |
| Jitendra Babulal Sanghvi | Non-Executive Director | June 30, 2026 |
| Sanjay Shaileshbhai Majmudar | Non-Executive Director | June 30, 2026 |
| Shah Arpit Deepakkumar | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
